期刊文献+

ABCG2在人皮肤鳞状细胞癌组织及A431侧群细胞中的表达及意义 被引量:2

Expression of adenosine triphosphate?鄄binding cassette transporter 2 in the tissue and side population of a cell line (A431) of human cutaneous squamous cell carcinoma and its significance
原文传递
导出
摘要 目的 探讨干细胞相关因子三磷酸腺苷(ATP)结合转运蛋白G超家族成员2(ATP-binding cassette transporter 2,ABCG2)在人皮肤鳞状细胞癌(鳞癌)组织及A431侧群细胞中的表达。方法 培养人A431细胞,流式细胞仪分选侧群细胞,噻唑蓝(MTT)实验比较侧群、非侧群细胞生长的增殖能力,逆转录PCR检测ABCG2在两者中的表达。免疫组化MaxVision法检测人鳞癌组织中ABCG2表达情况。结果 A431细胞系中存在侧群细胞,约占总细胞数的1.1%。侧群细胞具有较强的生长能力以及克隆形成能力,侧群组和非侧群组24孔板内每孔克隆形成数分别为114.8 ± 4.95和44.5 ± 3.67(t = 27.92,P < 0.01),且侧群细胞ABCG2 mRNA表达量明显高于非侧群细胞(t = 5.22,P < 0.01)。在人鳞癌组织中存在少量ABCG2阳性细胞,ABCG2蛋白主要表达在细胞胞质和胞膜上。结论 人鳞癌细胞A431中存在具有干细胞特性的侧群细胞,高表达ABCG2。ABCG2可作为鳞癌干细胞的表面标志物之一。 Objective To investigate the expression of stem cell marker adenosine triphosphate (ATP)-binding cassette transporter 2 (ABCG2) in the tissue and side population (SP) of a cell line A431 of human cutaneous squamous cell carcinoma (SCC). Methods SP cells were separated by flow cytometry from cultured A431 cells. Methyl thiazolyl tetrazolium (MTT) assay was used to evaluate the proliferative ability of, reverse transcription-PCR to determine the expression of ABCG2 in, SP and non-SP cells. Immunohistochemistry (MaxVision method) was carried out to detect the expression of ABCG2 protein in tissue specimens from 10 patients with SCC. Results SP cells existed in cultured A431 cells, and accounted for about 1.1% of A431 cells. The SP cells had a stronger growth and colony-forming ability than non-SP cells did. The number of cell clones formed by SP cells and non-SP cells was 114.8 ± 4.95 and 44.5 ± 3.67, respectively, per well in a 24-well plate (t = 27.92, P 〈 0.01). The expression level of ABCG2 mRNA was significantly higher in SP cells than in non-SP cells (t = 5.22, P 〈 0.01). There existed a small number of ABCG2 positive cells in SCC tissue, and ABCG2 was mainly expressed in the cytoplasm and membrane of tumor cells. Conclusions SP cells exist in A431 cells, which have characteristics of stem cells and highly express ABCG2. ABCG2 may be a potential stem cell surface marker of SCC.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2012年第6期392-395,共4页 Chinese Journal of Dermatology
基金 基金项目:江苏省自然科学基金(BK2009063)
关键词 A431细胞系 侧群细胞 干细胞 ABCG2 鳞状细胞癌 cell line A431 side population cells stem cells ABCG2 cutaneous sqamous cell carcinoma
  • 相关文献

参考文献1

二级参考文献31

  • 1Kondo T;Setoguchi T;Tags T.Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line,2004(03).
  • 2Yin AH;Miraglia S;Zanjani ED.AC133, a novel marker for human hematopoietic stem and progenitor cells,1997.
  • 3Miraglia S;Godfrey W;Yin AH.A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning,1997.
  • 4Goodell MA;Brose K;paradis G.Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo,1996.
  • 5Collins AT;Berry PA;Hyde C.Prospective identification of tumorigenic prostate cancer stem cells,2005.
  • 6Singh SK,Clarke ID,Terasaki M,et al.Identification of a cancer stem cell in human brain tumors. Cancer Research . 2003
  • 7Ricci-Vitiani L,Lombardi DG,Pilozzi E,et al.Identification and expansion of human colon-cancer-initiating cells. Nature . 2007
  • 8Hirschmann-Jax C,Foster AE,Wulf GG,et al.A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Sciences of the United States of America . 2004
  • 9Al-Hajj M,Wicha M S,Benito-Hernandez A,et al.Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America . 2003
  • 10Singh SK,Hawkins C,Clarke ID,et al.Identification of human brain tumour initiating cells. Nature . 2004

共引文献68

同被引文献52

  • 1王兵,刘文勇,叶冬霞,高钢龙,程海冰.肠癌SW480肿瘤细胞SP亚群分析[J].上海交通大学学报(医学版),2011,31(8):1113-1116. 被引量:2
  • 2岳保红,张秋堂,秦东春,孙玲,王清霞,刘帅,张钦宪.K562和HL60细胞分化抗原的表达[J].郑州大学学报(医学版),2006,41(3):467-470. 被引量:5
  • 3Guo J, Anderson MG, Tapang P, et al. Identification of genes that confer tumor cell resistance to the aurora B kinase inhibitor, AZD 1152[J]. Pharmacogenomics J,2009,9(2) :90-102.
  • 4Liu JJ, Lin M, Yu JY, et al. Targeting apoptotic and autophag- ic pathways for cancer therapeutics [J]. Cancer Lett, 2011, 300(2) 105 I14.
  • 5Ni Z, Bikadi Z, Rosenberg MF, et al. Structure and {unction of the human breast cancer resistance protein(BCRP/ABCG2)[J]. Curr Drug Metab,2010,11(7) :603-617.
  • 6Magee JA, Piskounova E, Morrison SJ. Cancer stem cells:im pact, heterogeneity, and uncertainty[J]. Cancer Cell, 2012, 21(3) :283 296.
  • 7Omran OM. The prognostic value of breast cancer resistance protein (BCRP/ABCG2) expression in breast carcinomas[J]. J Environ Pathol Toxicol ()ncol, 2012,31 (4) : 367 376.
  • 8Lee SH, Kim H, Hwang JH, ct al. Breast cancer resistance protein expression is associated with early recurrence and de creased survival in resectable pancreatic cancer patients [J]. Pathol Int,2012,62(3) : 167-175.
  • 9Abraham L, Eisayed K, Chen ZS, et al. Current status on ma- rine products with reversal effect on cancer multidrur resistance [J]. Mar Drugs,2012,10(10):2312 2321.
  • 10Sukowati CH, Rosso N, Pascut D, et al. Gene and functional up-regulation of the BCRP/ ABCG2 transporter in hepatocellular carcinoma[J]. BMC Gastroenterol, 2012,12 ( 1 ) : 160-167.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部